Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.34 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.34 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 4/20 | 0.33 |
| ▸ | XIAP | P98170 | 1/20 | 0.33 |
| ▸ | MLX | Q9UH92 | 1/20 | 0.33 |
| ▸ | BRAF | P15056 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | GPR88 | Q9GZN0 | 2/20 | 0.31 |
| ▸ | VHL | P40337 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27360679 | 0.92 | ROCK2 (0.37) | KCNH2ELANEXIAPMLXBRAF | |
| SCHEMBL27360587 | 0.87 | PTGES (0.35) | CYP3A4CYP2C9CYP1A2KCNH2ELANE | |
| SCHEMBL27360675 | 0.86 | ELANE (0.38) | CYP3A4KCNH2ELANEXIAPMLX | |
| SCHEMBL27360586 | 0.86 | DPP4 (0.40) | KCNH2ELANEXIAPMLXBRAF | |
| SCHEMBL27360670 | 0.86 | ELANE (0.36) | CYP3A4CYP2C9KCNH2ELANEXIAP | |
| SCHEMBL27360583 | 0.85 | DPP4 (0.37) | CYP3A4CYP2C9KCNH2ELANEXIAP | |
| SCHEMBL27360584 | 0.84 | ELANE (0.35) | CYP3A4CYP2C9KCNH2ELANEXIAP | |
| SCHEMBL27360356 | 0.77 | XIAP (0.37) | CYP3A4CYP2C9CYP1A2KCNH2NR1I2 | |
| SCHEMBL26847747 | 0.75 | VHL (0.51) | VHL | |
| SCHEMBL26786350 | 0.70 | VHL (0.57) | VHL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024040080-A1 | KRAS INHIBITOR CONJUGATES | ERASCA, INC. (US) | 2024-02-22 | — | — | WO | disclosed |